Dalmia Cement Acquires 34.52% Stake in Kilavikulam Rajalakshmi Solar to Boost Renewable Energy Goals

Dalmia Bharat Limited’s subsidiary, Dalmia Cement (Bharat) Limited, has announced the acquisition of a 34.52% stake in Kilavikulam Rajalakshmi Solar Power Developer Private Limited for ₹3 crore.

This strategic investment aligns with the company’s commitment to expanding its renewable energy portfolio.

Strengthening Renewable Energy Commitments

The acquisition is a key step in Dalmia Bharat’s sustainability roadmap, supporting its long-term goal of achieving 100% renewable energy (RE 100) by 2030 and becoming carbon-negative by 2040.

The company plans to utilise solar power from Kilavikulam Rajalakshmi Solar as a captive consumer, with a capacity of up to 10 MW in Tamil Nadu.

Completion Timeline and Regulatory Approvals

The acquisition process is expected to be completed within two months, subject to customary conditions and regulatory approvals.

This move reinforces Dalmia Cement’s commitment to sustainable energy and its strategic efforts to reduce carbon emissions through increased renewable energy adoption.

Stock Performance 

On March 06, 2025, Dalmia Bharat share price traded 0.06% lower at ₹1,708.10 at 10:17 AM (IST). Dalmia Bharat’s share price reached a 52-week high of ₹2,064.45 on April 03, 2024, and a 52-week low of ₹1,659.20 on March 04, 2025. As per BSE, the total traded volume for the stock stood at 1117 shares with a turnover of ₹19.12 lakhs.

At the current price, Dalmia Bharat shares are trading at a price-to-earnings (P/E) ratio of 258.41x, based on its trailing 12-month earnings per share (EPS) of ₹6.61, and a price-to-book (P/B) ratio of 3.93, according to exchange data.

 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Galaxy Surfactants Announces Strategic Collaboration for Overseas Manufacturing Plant

Mumbai-based speciality care products maker Galaxy Surfactants announced on Wednesday (March 5) that it has entered into a strategic collaboration through its group companies with a global customer to provide Engineering, Procurement, and Construction (EPC) services for performance surfactants and speciality ingredients manufacturing plant at an overseas location.

Key Aspects of the Collaboration

According to a regulatory filing, the collaboration involves providing process design, procurement, engineering, construction, and commissioning of the customer’s manufacturing facility. The move is expected to enhance Galaxy Surfactants’ global presence and strengthen its foothold in the surfactants and speciality ingredients sector.

Expansion of Partnership Post-Commissioning

The company further stated that it is in advanced discussions to expand its partnership with the customer beyond the commissioning of the plant. This expansion is expected to open new avenues for collaboration and business growth.

Confidentiality on Financial Terms

While the financial terms of the agreement have not been disclosed due to confidentiality agreements, the company emphasised that this partnership marks a significant step in strengthening its global operations and strategic alliances.

With this move, Galaxy Surfactants aims to bolster its presence in international markets, further cementing its position as a leading supplier of performance surfactants and specialty ingredients.

Stock Performance 

On March 06, 2025, Galaxy Surfactants share price ended 6.60% higher at ₹2,393.20 at 9:59 AM (IST). Galaxy Surfactants’s share price reached a 52-week high of ₹3,366.30 on September 17, 2024, and a 52-week low of ₹2,085.00 on March 03, 2025. As per BSE, the total traded volume for the stock stood at 558 shares with a turnover of ₹13.06 lakhs.

At the current price, Galaxy Surfactants shares are trading at a price-to-earnings (P/E) ratio of 49.39x, based on its trailing 12-month earnings per share (EPS) of ₹48.46, and a price-to-book (P/B) ratio of 5.94, according to exchange data.

 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Union Cabinet Approves ₹3,880 Crore Livestock Health and Disease Control Programme

The Union Cabinet on Wednesday approved the revision of the Livestock Health and Disease Control Programme (LHDCP) with an outlay of ₹3,880 crore for two years.

The scheme aims to enhance the animal health sector through comprehensive vaccination programs, capacity building, disease surveillance, and the strengthening of veterinary infrastructure.

Key Components of LHDCP

The revised LHDCP consists of three major components:

  1. National Animal Disease Control Programme (NADCP)
  2. Livestock Health & Disease Control (LH&DC)
  3. Pashu Aushadhi – a newly added component focusing on affordable veterinary medicines.

The programme also includes three sub-components:

  • Critical Animal Disease Control Programme (CADCP)
  • Establishment and Strengthening of Existing Veterinary Hospitals and Dispensaries – Mobile Veterinary Unit (ESVHD-MVU)
  • Assistance to States for Control of Animal Diseases (ASCAD)

Pashu Aushadhi: Enhancing Veterinary Medicine Access

A provision of ₹75 crore has been earmarked within the total scheme outlay to ensure access to quality and affordable generic veterinary medicines. These medicines will be distributed through PM-Kisan Samriddhi Kendras and Cooperative Societies, with incentives provided for their sale under the Pashu Aushadhi component.

How LHDCP Will Improve Livestock Health?

According to a government press release, livestock productivity is significantly impacted by diseases such as Foot and Mouth Disease (FMD), Brucellosis, Peste des Petits Ruminants (PPR), Cerebrospinal Fluid (CSF), and Lumpy Skin Disease. By implementing systematic vaccination programs, LHDCP aims to curb these diseases and prevent economic losses for farmers.

The scheme supports doorstep livestock healthcare services through Mobile Veterinary Units (ESVHD-MVU) and enhances access to veterinary medicines via Pashu Aushadhi. It will also focus on disease prevention through surveillance and healthcare infrastructure upgrades.

Conclusion

The implementation of LHDCP is expected to improve livestock productivity, generate employment, and encourage entrepreneurship in rural areas. By reducing disease-related losses, the programme will contribute to strengthening the rural economy and supporting farmers dependent on livestock for their livelihood.

With the government’s strong focus on improving livestock health and disease control, the revised LHDCP is set to play a crucial role in ensuring sustainable animal husbandry practices across the country.

 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their research and assessments to form an independent opinion about investment decisions.

Gensol Engineering Plans Major Debt Reduction Through Asset Sales

Gensol Engineering announced on Wednesday that proceeds from a series of asset divestments will be used to reduce debt, as the company seeks to address concerns raised by recent credit rating downgrades.

The firm acknowledged the rating downgrades by CARE and ICRA, attributing them to a short-term liquidity mismatch, which it assured is improving through customer payments.

“We understand the concerns these downgrades have raised and are committed to addressing them responsibly for all our stakeholders,” the company stated.

Denial of Falsification Claims and Formation of Review Committee

Gensol Engineering denied any involvement in “falsification claims” and announced the formation of a committee to comprehensively review the matter. “This underscores the company’s commitment to accountability, transparency, and sustainable business practices,” the firm said.

Financial Performance 

The company highlighted its robust financial performance, with an order book exceeding ₹7,000 crore. In the first nine months of the current fiscal year, Gensol Engineering reported a 42% growth in revenue to ₹1,056 crore, an 89% increase in EBITDA to ₹246 crore, and a 34% rise in profit to ₹67 crore.

“These are challenging times, and we are taking decisive steps toward strengthening our financial position and ensuring long-term financial stability,” it added.

Debt Reduction Measures and Asset Divestments

Gensol’s total current debt stands at ₹1,146 crore, against reserves of ₹589 crore, resulting in a debt-equity ratio of 1.95. However, the company stated that it has already reduced its debt obligation by ₹230 crore in the current financial year and has initiated asset divestments to further decrease its debt burden.

Among the planned divestments, the company will sell 2,997 electric vehicles worth ₹315 crore and a wholly-owned Gensol subsidiary for ₹350 crore. These transactions are expected to reduce its debt by ₹665 crore, bringing the debt-equity ratio down to 0.8.

Commitment to Achieving Zero Net Debt

Gensol reaffirmed its commitment to repaying existing debt and meeting working capital obligations using the proceeds from asset sales. “While the company continues to pay its debt obligations, all proceeds from the above initiatives will be directly utilised toward repaying our existing debt and working capital obligations,” the company stated.

Through these initiatives and future planned interventions, Gensol Engineering is resolute in its goal of achieving a zero net debt status.

“We are confident in our ability to navigate this period and emerge stronger. We value the trust of our stakeholders and will provide regular updates as we progress toward our financial goals,” the company concluded.

Stock Performance

On March 05, 2025, Gensol Engineering share price ended 9.99% lower at ₹372.60. Gensol Engineering’s share price reached a 52-week high of ₹1,125.75 on June 24, 2024, and a 52-week low of ₹372.60.00 on March 05, 2025. As per BSE, the total traded volume for the stock stood at 0.20 lakh shares with a turnover of ₹75.54 lakhs.

At the current price, Gensol Engineering shares are trading at a price-to-earnings (P/E) ratio of 11.01x, based on its trailing 12-month earnings per share (EPS) of ₹33.85, and a price-to-book (P/B) ratio of 2.20, according to exchange data.

 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

8th Pay Commission: Which Allowances Could Be Removed or Revised?

The Central government, in January, announced its decision to form the much-awaited 8th Pay Commission, which is expected to submit its recommendations early next year. As part of the next steps, the government is likely to announce the name of the chairman and two members of the commission next month.

With the process of forming the 8th Central Pay Commission (CPC) gaining momentum, all stakeholders, including government employees and pensioners, are keenly awaiting the appointment of its members. The official announcement regarding the members is expected next month.

Key Focus Areas of the 8th Pay Commission

Following the announcement, speculations have been rife regarding the fitment factor that will be used to revise salaries and pensions for central government employees and pensioners.

However, it is important to note that the Pay Commission’s role extends beyond just salary hikes. It is also responsible for reviewing allowances and other facilities provided to central government employees.

According to news reports, the commission may eliminate outdated and irrelevant allowances or introduce new ones if required. The 7th Pay Commission also undertook a similar review and removed several allowances that were deemed unnecessary.

Timeline and Expectations for the 8th Pay Commission

The terms of reference for the 8th Pay Commission, which outline its framework and scope of work, are expected to be finalised before April 2025. Additionally, the government is likely to finalise the names of the chairman and other members of the commission in the coming months.

Once constituted, the 8th Pay Commission may take about a year to compile its report. During this period, it will engage with various stakeholders, particularly representatives of central employees, to assess their demands and draft recommendations accordingly.

Now, all eyes are on the government to see how much of a financial boost central government employees receive from the 8th Pay Commission and whether new allowances will be introduced to improve their benefits.

Reforms Introduced by the 7th Pay Commission

The 7th Pay Commission had reviewed 196 allowances, of which only 95 allowances were approved. A total of 101 allowances were either abolished, merged with other allowances, or excluded from the final report.

In terms of salary revision, the 7th Pay Commission recommended a salary hike based on a fitment factor of 2.57, which set the minimum salary at Rs 18,000 and the maximum salary at Rs 2,25,000.

 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their research and assessments to form an independent opinion about investment decisions.

Nifty Weekly Expiry Today: Manappuram Finance under F&O Ban on March 06

The Nifty 50 index witnessed recovery ahead of its weekly expiry, showing a gradual upside on Wednesday, March 05, 2025. The index traded within a range-bound manner, oscillating between 22,067.80 and 22,394.90 levels. Despite the constrained movement, the Nifty 50 closed above the key 22,300 mark, ending the day with gains of 254.65 points at 22,337.30.

Stocks Under F&O Ban on Nifty’s Weekly Expiry Day

Ahead of the Nifty weekly expiry on Thursday, March 6, 2025, the National Stock Exchange (NSE) has placed one stock under a trading ban in the futures and options (F&O) segment. The restriction was imposed after the stock breached 95% of the market-wide position limit (MWPL). While F&O trading is restricted, the stock remains available for trading in the cash market.

The stocks under the F&O ban for March 06 include:

  • Manappuram Finance

On March 05, 2025, Manappuram Finance’ share price jumped 3.06%, closing at ₹203.65. According to BSE data, the stock recorded a total traded volume of 4.35 lakh shares, translating to a turnover of ₹8.77 crore.

At the current price, Manappuram Finance shares are trading at a price-to-earnings (P/E) ratio of 9.59x, based on its trailing 12-month earnings per share (EPS) of ₹21.23, and a price-to-book (P/B) ratio of 1.55, according to exchange data.

Why Are Stocks Under F&O Ban?

The National Stock Exchange (NSE) has placed a stock under its F&O ban period after its derivative contracts exceeded 95% of the market-wide position limit (MWPL). As per the NSE, traders can only reduce existing positions through offsetting trades, while new positions are prohibited.

Any attempt to increase open positions could lead to penal and disciplinary action. Despite the restriction in the F&O segment, the stock remains available for cash market trading.

About Nifty Weekly Expiry Day?

Nifty weekly futures and options (F&O) contracts typically expire every Thursday, unless it falls on a trading holiday, in which case the expiry shifts to the previous trading session. All contracts are settled at the normal market closing time on expiry day or at a later time as determined by the National Stock Exchange (NSE).

For individual securities, if the last Thursday of the expiry period is a holiday, the expiry moves to the preceding trading session. Notably, in MarketWatch, expiry dates for the final week’s contracts are not displayed, as they are classified as monthly contracts, showing only the month’s name and strike price.

Recent Shift in Expiry Days

The National Stock Exchange (NSE) has announced that starting April 4, 2025, all Nifty index weekly futures and options (F&O) contracts will expire on Monday instead of Thursday. Additionally, the expiry for Bank Nifty, FinNifty, Nifty Midcap Select, and Nifty Next50 F&O contracts will also shift to the last Monday of the expiry month.

According to NSE, this change will come into effect from April 4, 2025, and all existing contracts will be revised to the new expiry day on April 3, 2025 (EOD).

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Stocks To Watch Today on March 06, 2025: Wipro, TCS, Zydus Lifesciences and More in Focus

Indian markets are expected to be impacted today. At 7:16 AM, GIFT Nifty futures were up by 38.50 points at 22,459.00.

In the previous session, the Sensex surged by 740.30 points (1.01%) to 73,730.23, while the Nifty50 jumped by 254.65 points (1.15%) to 22,337.30.

Here are the key stocks to watch today on March 05, 2025:

Wipro

IT giant Wipro has launched TelcoAI360, an AI-powered platform aimed at helping telecom companies optimize services by reducing costs, improving customer experience, and strengthening network security. Developed with support from ServiceNow and Wipro’s AI partners, the platform leverages advanced AI capabilities to drive efficiency and innovation in the telecom sector.

TCS

Tata Consultancy Services (TCS) has collaborated with Vantage Towers, a leading European telecom tower operator, to introduce a digital service platform aimed at streamlining processes for property owners leasing land for telecom towers. The platform is designed to simplify site management and enhance partnerships, making operations more efficient for stakeholders.

Zydus Lifesciences

Zydus Lifesciences has received final approval from the USFDA to market Dasatinib tablets in multiple strengths. The drug is a generic version of Sprycel, a leukaemia treatment with annual U.S. sales of $1.81 billion. This approval strengthens Zydus’ portfolio in the oncology segment.

LIC Housing Finance

LIC Housing Finance, a leading mortgage lender, has approved a plan to raise ₹1,22,500 crore in the next financial year. The funds will be sourced through loans, bonds, commercial papers, and external borrowings to strengthen lending operations and support business growth.

Hindustan Zinc 

The board of Hindustan Zinc will meet on March 10 to consider raising funds through listed non-convertible debentures (NCDs) on a private placement basis.

RPP Infra Projects

RPP Infra Projects has secured a ₹80.98 crore contract to enhance Chennai’s water supply infrastructure. The project includes the construction of underground tanks, feeder mains, and distribution stations to improve water distribution in key areas of the city.

Galaxy Surfactants

Galaxy Surfactants, through its group companies, has entered into a strategic collaboration with a global customer to provide engineering, procurement, and construction (EPC) services for a performance surfactants and speciality ingredients manufacturing plant at an overseas location. The partnership covers process design, procurement, engineering, construction, and commissioning of the facility.

Route Mobile

Proximus Global, comprising BICS, Telesign, and Route Mobile, has partnered with Nokia to explore network API solutions. The collaboration aims to support developers in financial services, healthcare, and enterprise applications, enhancing connectivity and innovation across industries.

Walchandnagar Industries 

Sandeep Jain has stepped down as Chief Financial Officer (CFO) of Walchandnagar Industries due to health reasons. Nishant Saigal will take over the role effective April 14, 2025.

Dalmia Bharat

Dalmia Bharat is set to acquire a 34.52% stake in Kilavikulam Rajalakshmi Solar Power Developer for ₹3 crore. The deal, which covers up to 10 MW of solar capacity in Tamil Nadu, is expected to be completed within two months.

Kirloskar Industries

Mahesh Chhabria, who announced his early retirement as Managing Director in November 2024 in Kirloskar Industries, has now also resigned as a Director. His exit will be effective from March 31, 2025.

Conclusion

Indian markets are set for impact today, with GIFT Nifty up 38.50 points. Key stocks in focus include Wipro, TCS, Zydus Lifesciences, and LIC Housing Finance, among others, due to major business moves, fundraises, approvals, and partnerships. Notable executive changes include exits at Kirloskar Industries and Walchandnagar Industries.

 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Bajaj Auto Share Price Hits New 52-week Low on March 05, 2025

On March 05, 2025, Bajaj Auto share price traded 0.67% higher at ₹7,385.80 at 12:01 AM (IST). Bajaj Auto’s share price reached a 52-week high of ₹12,772.15 on September 27, 2024, and a 52-week low of ₹7,308.00 on March 05, 2025. As per BSE, the total traded volume for the stock stood at 7,508 shares with a turnover of ₹5.52 crores.

At the current price, Bajaj Auto shares are trading at a price-to-earnings (P/E) ratio of 25.66x, based on its trailing 12-month earnings per share (EPS) of ₹287.84, and a price-to-book (P/B) ratio of 7.55, according to exchange data.

Shareholding Details

As of December 31, 2024, Bajaj Auto’s shareholding structure was led by its promoters, who held a 55.04% stake in the company. Foreign Institutional Investors (FIIs) owned 12.45%, while Domestic Institutional Investors (DIIs) accounted for 9.98% of the total shareholding.

Bajaj Auto Q3 FY25 Results

Pune-based Bajaj Auto reported an 8% year-on-year (YoY) increase in consolidated profit after tax (PAT) for Q3FY25, reaching ₹2,196 crore, while its revenue grew by 8.2% to ₹13,169 crore.

The company’s EBITDA margin remained steady at 20.2% for the fifth consecutive quarter, as favourable USD-INR realisations, strategic pricing, and cost efficiencies helped offset significant investments in key business priorities.

Bajaj Auto recently expanded into CNG bikes and saw its Chetak become the best-selling electric scooter in December.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Gensol Engineering Share Price Trades 9.99% Lower to 52-week Low on March 05, 2025

On March 05, 2025, Gensol Engineering share price traded 9.99% lower at ₹372.60 at 11:24 AM (IST). Gensol Engineering’s share price reached a 52-week high of ₹1,125.75 on June 24, 2024, and a 52-week low of ₹372.60 on March 05, 2025. As per BSE, the total traded volume for the stock stood at 0.15 lakh shares with a turnover of ₹54.79 lakhs.

At the current price, Gensol Engineering shares are trading at a price-to-earnings (P/E) ratio of 11.01x, based on its trailing 12-month earnings per share (EPS) of ₹33.85, and a price-to-book (P/B) ratio of 2.20, according to exchange data.

Shareholding Details

As of December 31, 2024, Gensol Engineering’s shareholding structure comprised 62.66% ownership by its promoters, while the government held a 1.37% stake. The remaining 35.34% was owned by public retail investors.

Gensol Engineering Q3 FY25 Results

For the quarter ending December 2024, Gensol Engineering reported a 57% year-on-year (YoY) increase in sales, rising from ₹220 crore in December 2023 to ₹345 crore in December 2024.

Net profit also saw a 50% YoY jump, climbing from ₹12 crore to ₹18 crore. However, on a quarter-on-quarter (QoQ) basis, sales remained flat, while net profit declined by 22%.

The company’s Solar EPC segment saw a significant drop in profit before tax, falling 57% from ₹35.6 crore in December 2023 to ₹15.4 crore in December 2024.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

BSE Shares Plunge 9% as NSE Moves Weekly Contract Expiry to Monday

Shares of Bombay Stock Exchange Ltd. (BSE) fell as much as 9% on Wednesday, March 5, in early morning trade after the National Stock Exchange (NSE) announced a change in the expiry day of its weekly and monthly contracts.

On Tuesday evening, March 4, NSE stated that Nifty weekly contracts, which currently expire on Thursdays, will now expire on Mondays. This change appears to have impacted investor sentiment, leading to a sharp decline in BSE’s stock price.

Stock Performance and Key Levels

At 11:53 AM (IST) on March 5, 2025, BSE share price was trading 5.67% lower at ₹4,201.00. The stock had previously hit a 52-week high of ₹6,133.40 on January 20, 2025, while its 52-week low stood at ₹1,941.05 on March 19, 2024.

As per NSE data, the total traded volume for BSE shares stood at 55.73 lakh, with a turnover of ₹2,309.78 crore.

At its current price, BSE shares are trading at a price-to-earnings (P/E) ratio of 71.42x, based on its trailing 12-month earnings per share (EPS) of ₹69.33. The stock’s price-to-book (P/B) ratio stands at 22.93, according to exchange data.

Shareholding Structure

As of December 31, 2024, the shareholding pattern of BSE was as follows:

  • Foreign Institutional Investors (FIIs): 16.03%
  • Domestic Institutional Investors (DIIs): 12.07%
  • Public (Retail Investors): 50%

The decline in BSE’s stock price highlights the market’s reaction to NSE’s contract expiry adjustments, with investors closely monitoring further developments.

BSE Q3 FY25 Results

Leading stock exchange BSE reported a net profit of ₹220 crore for the quarter ended December 2024, doubling from ₹108.2 crore in the same period last fiscal.

The exchange also recorded its highest-ever quarterly revenue of ₹835.4 crore in Q3 FY25, marking a 94% surge from ₹431.4 crore in the corresponding period of the previous year.

Additionally, BSE witnessed an average daily turnover of ₹6,800 crore during the quarter, compared to ₹6,643 crore a year ago.

 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.